R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises. With WHO as convener, the broad global coalition of experts who have contributed to the Blueprint come from medical, scientific and regulatory backgrounds. WHO Member States welcomed the development of the Blueprint at the World Health Assembly in May 2016.

Key actions by disease

Publications

These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the...

Targeted Update: Safety and efficacy of hydroxychloroquine or chloroquine for treatment of COVID-19

在线观看|影视免费观看vipThis targeted update includes data from RCTs and quasi-experimental studies comparing the use of hydroxychloroquine or chloroquine (with or without a macrolide)...

Criteria for COVID-19 vaccine prioritization

Purpose of the document The proposed attributes and criteria provide considerations for the evaluation and prioritization of COVID-19 candidate vaccines...

This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...

在线观看|影视免费观看vipThere has been some suggestions for the inclusion of Favipiravir in the Solidarity trial. 

在线观看|影视免费观看vipCurrently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...

Related health topics